| Vol. 10.38 – 28 September, 2022 |
| |
|
|
| Plasma cell depletions demonstrated that plasma cells must reside within olfactory tissue to achieve sterilizing immunity. Antibody blockade and genetically deficient models revealed that this local immunity required CD4+ T cells and CXCR3. [Immunity] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| Scientists examined the memory antibodies that develop after a third or fourth antigenic exposure by Delta or Omicron BA.1 infection, respectively. [Journal of Experimental Medicine] |
|
|
|
| Buffer optimization allowed the determination of lyophilization conditions, where lipid nanoparticle-encapsulated mRNA encoding SARS-CoV-2 spike protein could induce robust immunogenicity in mice after one month of storage at 5°C and 25°C. [Molecular Therapy-Nucleic Acids] |
|
|
|
| Researchers investigated whether camostat mesilate is an effective treatment for SARS-CoV-2 infection. This was a multicenter, double-blind, randomized, parallel-group, placebo-controlled study. [BMC Medicine] |
|
|
|
| The authors analyzed whether exposure to influenza A virus antigens could influence the T cell repertoire in response to SARS-CoV-2, indicating a heterologous immune response between these 2 unrelated viruses. [JCI Insight] |
|
|
|
| Scientists screened adjuvants for the highest quality antibody titers, negated the concern of pre-existing rabies-vector immunity, and established its potential as a long-term COVID-19 vaccine. [NPJ Vaccines] |
|
|
|
| In this cross-sectional study, researchers examined serological and cell-mediated immune memory to SARS-CoV-2 variants, including Omicron, among a cohort of 18-21-year-old Marines with a history of either asymptomatic or mild SARS-CoV-2 infection 6 to 14 months earlier. [iScience] |
|
|
|
| Investigators analyzed spike receptor-binding domain-specific IgG, IgA, and IgM by enzyme-linked immunosorbent assay, neutralizing antibody titers against live SARS-CoV-2 variants, and antibody-depended cell-mediated phagocytosis in 99 randomly selected individuals. [Med] |
|
|
|
MORE IMMUNOLOGY OF INFECTIOUS DISEASE |
| | Scientists tested the hypothesis that passive transfer of herpes simplex virus (HSV)-specific human mAbs can prevent mortality and morbidity associated with neonatal HSV. [Journal of Experimental Medicine] |
|
|
|
| Injection of a lentiviral vector encoding an MHC class I–restricted T cell epitope of lymphocytic choriomeningitis virus and CD40 ligand induced an antigen-specific cytolytic CD8+ T lymphocyte response that protected the mice from infection. [JCI Insight] |
|
|
|
| To obtain novel biomarkers that serve as prompt indicators of sepsis, the current study screened the differentially expressed microRNAs that were associated with sepsis susceptibility. [Molecular Medicine Reports] |
| |
|
|
|
| The authors discuss recent reports on the mechanisms used by Zika virus to replicate efficiently, and they highlight potential new areas of research for the development of therapeutic approaches. [Annual Review of Pathology-Mechanisms of Disease] |
|
|
|
|
| Pfizer announced positive top-line results from its pivotal EU Phase III study in infants evaluating its 20-valent pneumococcal conjugate vaccine candidate for the prevention of invasive pneumococcal disease, pneumonia, and acute otitis media. [Pfizer] |
|
|
|
| InnoCare Pharma announced that the Company has received Investigational New Drug approval of clinical trial from the National Medical Products Administration for its B cell lymphoma-2 inhibitor ICP-248. [InnoCare Pharma] |
|
|
|
|
| May 28-31, 2023 Vancouver, British Columbia, Canada |
|
|
|
|
|
| The University of British Columbia – Vancouver, British Columbia, Canada |
|
|
|
| University of Calgary – Calgary, Alberta, Canada |
|
|
|
| University of Stavanger – Stavanger, Norway |
|
|
|
| University of Wisconsin-Madison – Madison, Wisconsin, United States |
|
|
|
| CRUK Beatson Institute for Cancer Research – Glasgow, United Kingdom |
|
|
|
|